CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies

Keyphrases

• Hematological Malignancies 100%
• Novel Therapeutics 100%
• Targeting Antibodies 100%
• Cluster of Differentiation 47 (CD47) 100%
• Clinical Trials 20%
• Macrophages 20%
• Tumor Cells 20%
• Host Cell 20%
• Overexpressing 20%
• Bispecific Antibody 20%
• Solid Tumors 20%
• Phagocytosis 20%
• Surface Glycoprotein 20%
• Hematological Cancer 20%
• Signal Regulatory Protein α (SIRPα) 20%
• Immune Checkpoint 20%
• Immune Surveillance 20%
• Don't Eat Me Signal 20%

Immunology and Microbiology

• CD47 100%
• Immunology 100%
• Tumor Cell 20%
• Macrophage 20%
• Host Cell 20%
• Glycoprotein 20%
• Phagocytosis 20%
• Immunity 20%
• Immunosurveillance 20%
• Bispecific Antibody 20%